Respiratory tract distribution and bioavailability of spiramycin in calves.
Pharmacokinetic determinants of spiramycin and its distribution into the respiratory tract were studied in 2 groups of calves, 4 to 10 weeks old. Group-A calves (n = 4) were used to determine pharmacokinetic variables of spiramycin after IV (15 and 30 mg/kg of body weight) and oral administrations of the drug (30 mg/kg) and to measure distribution of spiramycin into nasal and bronchial secretions. Group-B calves (n = 4) were used to determine distribution of spiramycin into lung tissue and bronchial mucosa. Spiramycin disposition was best described by use of an open 3-compartment model. Mean (+/- SD) elimination half-life was 28.7 +/- 12.3 hours, and steady-state volume of distribution was 23.5 +/- 6.0 L/kg. Bio-availability after oral administration was 4 +/- 3%. High and persistent concentrations of spiramycin were achieved in the respiratory tract tissues and fluids. Tissue-to-plasma concentration ratio was 58 for lung tissue and 18 for bronchial mucosa at 3 hours after spiramycin administration and 137 and 49, respectively at 24 hours. Secretion-to-plasma concentration ratio was 4 for nasal secretions and 7 for bronchial secretions, and remained almost constant with time. Thus, spiramycin penetrates well into the respiratory tract, although the value in bronchial secretions is lower than that in lung tissues and bronchial mucosa. Calculations indicate that a loading dose of 45 mg/kg, administered IV, followed by a maintenance dose of 20 mg/kg, IV, once daily is required to maintain active concentrations of spiramycin against bovine pathogens in bronchial secretions.
Department of Pharmacology and Toxicology, Royal Veterinary and Agricultural University, Copenhagen, Denmark.
C
C
Friis
E
E
Erhardsen
E B
EB
Madsen
P
P
Nielsen
K
K
Raun
D000818:Animals; D001682:Biological Availability; D001798:Blood Proteins / Q000378:metabolism; D001980:Bronchi / Q000378:metabolism*; D002417:Cattle / Q000378:metabolism*; D006207:Half-Life; D008168:Lung / Q000378:metabolism*; D009092:Mucous Membrane / Q000378:metabolism; D009297:Nasal Mucosa / Q000378:metabolism; D011485:Protein Binding; D015572:Spiramycin / Q000097:blood / Q000493:pharmacokinetics*; D014018:Tissue Distribution
D001798:Blood Proteins; D015572:Spiramycin